| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |